Gecacitinib Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 1/2: 1

Top Sponsors

Suzhou Zelgen Biopharmaceuticals Co.,Ltd1
Institute of Hematology & Blood Diseases Hospital, China1

Indications

Cancer2
Ph-Like1
Acute Lymphoblastic Leukemia1
Cervical Cancer1

Other2 trials

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

N/A

Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.